Pharmaceutical Executive
May 01, 2009
Column
0
0
Congress-and the public-needs to take a deep breath before making a big mistake.
May 01, 2009
Features
0
0
Despite the downside in ad spend, an upside remains in the digital space that's wide open for exploration.
May 01, 2009
Features
0
0
We leap tall buildings to bring you the definitive guide to the world's top pharmaceutical companies.
May 01, 2009
Columns
0
0
In an era of shrinking marketing budgets, increase ROI with behavioral science-based marketing.
May 01, 2009
Columns
0
0
Pharma marketers face a crisis in digital media. But there's a way to turn it around.
May 01, 2009
Features
0
0
When it comes to licensing in this market, there are winners and losers. Learn the new rules of the game.
May 01, 2009
Features
0
0
Tough economic tmes call for a bold approach to evolving information technology solutions.
May 01, 2009
Columns
0
0
Marketers must stress that maintaining good health behaviors is one of the best things people can do to survive a down market.
May 01, 2009
Washington Report
0
0
Pharma fears comparative effectiveness research will focus on costs and stymie personalized medicine.
May 01, 2009
From the Editor
0
0
Our 3-D cover jumps off the page. But the real question for us (and for you) is how do we get everything else to connect?